Sharp · client: Kddi
Electronics company Sharp is working with telco KDDI to build what it claims will be Asia's largest AI data center on the site of a former LCD screen manufacturing plant in Osaka, Japan.
Company lists
Drug development, genomics, medical devices, life science software, neurology and more: the companies building life sciences in Pennsylvania, with their founders, funding, team size and business models.
Funding, M&A, contract wins and launches involving 1,029 life sciences companies in Pennsylvania, last 24 months: 112 M&A deals · 108 funding rounds · 36 Contracts · 5 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.
Electronics company Sharp is working with telco KDDI to build what it claims will be Asia's largest AI data center on the site of a former LCD screen manufacturing plant in Osaka, Japan.
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. acquired a new stake in Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) during the fourth quarter, according to its…
The aggregate gross proceeds to Mineralys from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be…
In first place was Avalo Therapeutics, which priced a $375 million public offering to advance the clinical development of its candidate abdakibart, including through its phase 3 topline…
Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA ), a clinical-stage biotechnology company focused on developing and launching curative targeted cell therapies designed…
Royal Bank of Canada raised its stake in Viking Therapeutics by 13.0% in the 1st quarter.
Northwestern Mutual Wealth Management Co. raised its stake in Viking Therapeutics by 29.5% in the 2nd quarter.
Integrated Wealth Concepts LLC bought a new stake in Viking Therapeutics in the 1st quarter valued at about $230,000.
Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the fourth quarter, Holdings Channel reports.
Prudential Financial Inc. bought a new stake in Viking Therapeutics in the 2nd quarter valued at about $196,000.
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Viking Therapeutics by 1.4% in the 1st quarter.
Datavault AI (NASDAQ: DVLT) announced it has executed a binding term sheet with Scilex Holding Company for a $120 million upfront cash contribution tied to a revenue participation…
BioMarin Pharmaceutical Inc. said today that it completed the previously announced agreement to acquire Amicus Therapeutics for $14.50 per share in an all-cash transaction for a total…
Bloomberg News reported on Tuesday that the two companies were looking at taking over Teleflex.
Blue Mountain, a US enterprise asset management software provider for the life sciences sector (EAM), has today (22 April) announced the acquisition of Cork-based CompuCal Calibration…
Private equity firms CVC Capital Partners and GTCR have made a joint proposal to acquire medical device manufacturer Teleflex and take the company private, according to a report by…
US life sciences services firm Blue Mountain has acquired Cork-based CompuCal Calibration for an undisclosed sum.
MassMutual Private Wealth & Trust FSB raised its holdings in Teleflex by 57.9% in the 3rd quarter.
Mirae Asset Global Investments Co. Ltd. purchased a new stake in Teleflex in the 3rd quarter valued at about $35,000.
Hantz Financial Services Inc. raised its holdings in Teleflex by 248.8% in the 3rd quarter.
Signant Health has acquired Ametris, a wearable digital health systems manufacturer, in a tech M&A deal.
V Square Quantitative Management LLC purchased a new stake in Teleflex in the 4th quarter valued at about $37,000.
Quent Capital LLC purchased a new stake in Teleflex in the 3rd quarter valued at about $38,000.
Waterfront Wealth Inc. acquired a new stake in Teleflex Incorporated (NYSE:TFX – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and…
RTW Biotech Opportunities Ltd, a London-listed investment company focused on the life sciences sector, said Tuesday that portfolio company Obsidian Therapeutics Inc. has agreed to merge…
emagine announces today that it has acquired Gentis’ consulting operations in Belgium, Luxembourg, and France
Relmada Therapeutics bagged $160 million from a private investment in public equity (PIPE) financing.
Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the third tranche (the "Third Tranche") of its previously…
Teleflex, a leading global provider of medical technologies, is now live globally with Demand Planning and Supply Planning on the o9 platform.
Avisi Technologies – $10.8M
Few life sciences companies in Pennsylvania publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 670 active companies.

Developer of therapeutics for the treatment of autoimmune diseases and cancer
OncologyUS$410.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for rare neurological diseases
Rare diseasesUS$345.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for the treatment of cancer
OncologyUS$236.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of gene therapies for CNS rare diseases
Rare diseasesUS$225.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of medical devices for hypertension and atherosclerosis treatment
Cardiac and vascular disordersUS$205.88m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Personalized immunotherapies targeting solid tumors, stimulating innate and adaptive immunity
ImmunotherapyUS$203.83m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Biodiffusion chambers for advanced cell culture and drug screening applications.
CPC A61K31/7125, A61M31/002, C07K16/2896Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small-molecule therapeutics for the treatment of CNS and inflammatory diseases
NeurologyUS$194.37m across 11 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic Kv7 potassium channel activators for neurological and psychiatric disorders
CPC A61K31/428, C07D235/30, C07D235/32Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of gene therapy based platform for treatment of rare diseases
Rare diseasesUS$192.80m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Transforming neurohealth with innovative, non-drug TMS therapy for mental health
NeurologyUS$177.80m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Precise transcranial magnetic stimulation coil positioning, monitoring, and brain‑target modeling.
CPC A61N2/006, A61N2/02, A61N2/008Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of tissue-targeted genetic medicines for rare diseases
Rare diseasesUS$177.37m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted siRNA delivery via FN3 domains binding CD71 for enzyme replacement therapy
CPC C12N15/1138, C07K14/78, A61K47/6435Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of spinal devices to treat degenerative disc disease
OrthopedicsUS$175.95m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Spinal intervertebral fixation implants with tissue‑sparing insertion mechanisms
CPC A61F2/4455, A61F2/447, A61F2/4465Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapy for the treatment of hypertension
Cardiac and vascular disordersUS$158.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule inhibitors to treat Myelodysplastic syndrome and other cancers
OncologyUS$157.75m across 10 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of novel drugs to treat metabolic and cardiopulmonary disorders
Metabolic diseasesUS$152.38m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K38/2278, C07K14/62, A61K38/24Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of gene therapy medicines for neurological diseases
NeurologyUS$151.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of chromatin function targeting drugs for the treatment of cancer and rare diseases
OncologyUS$145.00m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Small‑molecule inhibitors of kinases and epigenetic enzymes for oncology therapeutics.
CPC C07D487/04, C07D487/14, C07D495/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of chemoprotective agents for oral mucositis associated with chemotherapy
OncologyUS$144.24m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Metal‑chelate macrocyclic complexes for oral cancer drugs and radiopharmaceutical protection
CPC A61K31/555, C07F13/005, A61K31/375Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of outpatient management solutions for monitoring clinical information
Disease self managementUS$141.90m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of an AI and cloud-based digital pathology solution for cancer diagnosis
Clinical labs itUS$129.23m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: AI-driven image analysis and workflow automation for digital pathology diagnostics
CPC G06T7/0012, G16H50/30, G16H30/40Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of antibiotics to target MDR bacteria
Infectious diseasesUS$120.45m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Antimicrobial peptide therapeutics and AI-driven peptide drug design and optimization
CPC G06F16/2428, G16B40/00, C07K14/001Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapies for cancer treatment
OncologyUS$119.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of GPCR ligand technology based therapeutics for cardiovascular diseases and pain
NeurologyUS$119.00m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C07K7/06, C07D401/12, A61K31/4436Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a non-drug non-invasive therapeutic devices for neurorehabilitation
NeurologyUS$118.69m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of AI-based platform for lab-grown human tissues
Life sciences platforms and toolsUS$117.69m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a device for the treatment of abdominal aortic aneurysms
Cardiac and vascular disordersUS$115.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Online genetic engineering tool for drug development
Life sciences techUS$115.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Manufacturer of mass spectroscopy instruments for clinical solutions
Life sciences platforms and toolsUS$114.50m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of gene therapies for the treatment of coronary arterial disease
GenomicsUS$110.90m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a device for removal of vascular blockages
Cardiac and vascular disordersUS$110.42m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Drug‑coated, serrated‑balloon catheters for targeted vascular lesion therapy
CPC A61M25/104, A61M25/1029, A61B17/320725Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of medical device for orthopedic diseases
OrthopedicsUS$110.05m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing long acting formulation for opioid addiction
Life sciences platforms and toolsFocus: Vehicle temperature control systems for passenger and commercial vehicles.
CPC B60H1/00742Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of biologically active molecules for the treatment of Periodontitis and inflammation diseases
ImmunologyUS$105.78m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction
Genitourinary disordersUS$104.10m across 9 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of novel cancer immunotherapies to treat cancer and infectious disease
ImmunotherapyFocus: Engineered T-cell receptor therapies for targeted cancer immunotherapy
CPC A61K38/177, C07K14/7051Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Device to measure dark adaptation function to diagnose retinal disease
OphthalmologyUS$103.83m across 9 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

US-based, clinical stage biotech developing beta-lactamase inhibitors for DR infections
Infectious diseasesUS$102.73m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule drugs for cancer treatment
OncologyUS$96.40m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of CAAR T cells for B cell-mediated autoimmune diseases
Rare diseasesUS$88.26m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Minimally invasive solutions for orthopedic and podiatric procedures, improving patient outcomes
DiabetesUS$85.47m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of gene therapies for rare diseases
GenomicsUS$85.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C12N15/111, A61K47/6455, A61K47/6881Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Biopharmaceutical company empowering patients through therapeutic innovation in immuno-inflammatory conditions
DermatologyUS$82.00m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C07D471/04, A61K31/506, C07D401/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of cell and gene therapies to treat multiple diseases
Gene therapyUS$80.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of oral treatment for postmenopausal osteoporosis
OrthopedicsUS$76.69m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapies for treating cancer and inflammatory diseases
OncologyUS$71.88m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of CRISPR-based therapies to cure viral infectious diseases
Infectious diseasesUS$70.74m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of CAR-T cell therapies for cancer
OncologyUS$70.15m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of endovascular catheters for acute venous thromboembolic conditions
Cardiac and vascular disordersUS$67.84m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Thrombolex patents cover catheter-based thrombus removal baskets and infusion delivery systems.
CPC A61B17/221, A61M25/10, A61M25/0074Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics to treat rare diseases
Rare diseasesUS$65.44m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of genetic tests for personalised medicines to enhance mental health treatment
NeurologyUS$64.42m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Pharmacogenomic allele detection and reporting for mental health drug response
CPC C12Q1/6883, A61K31/554, G16B20/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a drug discovery platform for cancer therapies
Life sciences techUS$55.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic antibodies targeting CD161 for immune modulation and related diagnostics
CPC C07K16/2851Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in Pennsylvania on RadarFind top life sciences companies in Pennsylvania across drug development, genomics and medical devices. Explore life sciences startups in Pennsylvania and specialist healthcare technology providers.
Companies developing therapies, cancer treatments and medicines.

Developer of therapeutics for the treatment of autoimmune diseases and cancer
Oncology
Developer of gene therapies for CNS rare diseases
Rare diseases
Personalized immunotherapies targeting solid tumors, stimulating innate and adaptive immunity
Immunotherapy
Developer of small molecule inhibitors to treat Myelodysplastic syndrome and other cancers
Oncology
Developer of gene therapy medicines for neurological diseases
NeurologyCompanies working in genomics, clinical testing and gene therapy.

Developer of gene therapies for CNS rare diseases
Rare diseases
Developer of gene therapy medicines for neurological diseases
Neurology
Online genetic engineering tool for drug development
Life sciences tech
Developer of gene therapies for the treatment of coronary arterial disease
Genomics
Developer of genetic tests for personalised medicines to enhance mental health treatment
NeurologyCompanies building medical devices, diagnostic equipment and therapeutic tools.

Developer of medical devices for hypertension and atherosclerosis treatment
Cardiac and vascular disorders
Transforming neurohealth with innovative, non-drug TMS therapy for mental health
Neurology
Developer of spinal devices to treat degenerative disc disease
Orthopedics
Provider of a non-drug non-invasive therapeutic devices for neurorehabilitation
Neurology
Developer of a device for the treatment of abdominal aortic aneurysms
Cardiac and vascular disordersSoftware, laboratory tools and platforms for life science research.

Provider of an AI and cloud-based digital pathology solution for cancer diagnosis
Clinical labs it
Developer of AI-based platform for lab-grown human tissues
Life sciences platforms and tools
Online genetic engineering tool for drug development
Life sciences tech
Developing long acting formulation for opioid addiction
Life sciences platforms and tools
Developer of a drug discovery platform for cancer therapies
Life sciences techCompanies focused on neurological, ophthalmology and rare-disease care.

Developer of therapeutics for rare neurological diseases
Rare diseases
Developer of gene therapies for CNS rare diseases
Rare diseases
Transforming neurohealth with innovative, non-drug TMS therapy for mental health
Neurology
Developer of tissue-targeted genetic medicines for rare diseases
Rare diseases
Developer of GPCR ligand technology based therapeutics for cardiovascular diseases and pain
NeurologyListed life sciences companies based in Pennsylvania.

Developer of therapeutics for the treatment of autoimmune diseases and cancer
Oncology
Developer of therapeutics for rare neurological diseases
Rare diseases
Developer of gene therapies for CNS rare diseases
Rare diseases
Developer of medical devices for hypertension and atherosclerosis treatment
Cardiac and vascular disorders
Developer of therapy for the treatment of hypertension
Cardiac and vascular disordersRecently founded life sciences companies in Pennsylvania.

Developer of therapeutics for the treatment of cancer
Oncology
Developer of gene therapy medicines for neurological diseases
Neurology
Developer of AI-based platform for lab-grown human tissues
Life sciences platforms and tools
Developer of psychedelic-based therapeutics for mental health conditions
Neurology
Developer of T-cell therapies to address various medical conditions
Cell therapyLife sciences employers in Pennsylvania with hiring activity.

Developer of therapeutics for rare neurological diseases
Rare diseases
Developer of medical devices for hypertension and atherosclerosis treatment
Cardiac and vascular disorders
Provider of gene therapy based platform for treatment of rare diseases
Rare diseases
Transforming neurohealth with innovative, non-drug TMS therapy for mental health
Neurology
Developer of tissue-targeted genetic medicines for rare diseases
Rare diseasesThe most-installed Android apps published by life sciences companies headquartered in Pennsylvania — 46K installs between them. 7 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Pennsylvania compares. Debt, IPO and grant rounds are excluded.
US$13.54bn
US$37.38bn
5,603 rounds in the United States
last 24 months
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
Equity rounds over the last five years, 1,029 life sciences companies in Pennsylvania among 27,407 in the United States.
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of the United StatesThe financials above are one chapter. The full life sciences landscape of Pennsylvania maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
236 life sciences companies in Pennsylvania have recorded equity funding, US$8.36bn in total. Totals and round dates describe the historical record; they are not current valuations.
Largest recorded equity totals, with the latest recorded round.
OncologyDeveloper of therapeutics for the treatment of autoimmune diseases and cancer
Rare diseasesDeveloper of therapeutics for rare neurological diseases
OncologyDeveloper of therapeutics for the treatment of cancer
Rare diseasesDeveloper of gene therapies for CNS rare diseases
Cardiac and vascular disordersDeveloper of medical devices for hypertension and atherosclerosis treatment
ImmunotherapyPersonalized immunotherapies targeting solid tumors, stimulating innate and adaptive immunity
NeurologyDeveloper of small-molecule therapeutics for the treatment of CNS and inflammatory diseases
Rare diseasesProvider of gene therapy based platform for treatment of rare diseases
NeurologyTransforming neurohealth with innovative, non-drug TMS therapy for mental health
Rare diseasesDeveloper of tissue-targeted genetic medicines for rare diseases
OrthopedicsDeveloper of spinal devices to treat degenerative disc disease
Cardiac and vascular disordersDeveloper of therapy for the treatment of hypertension
Founders
Details not available
OncologyDeveloper of small molecule inhibitors to treat Myelodysplastic syndrome and other cancers
Metabolic diseasesDeveloper of novel drugs to treat metabolic and cardiopulmonary disorders
NeurologyDeveloper of gene therapy medicines for neurological diseases
OncologyDeveloper of chromatin function targeting drugs for the treatment of cancer and rare diseases
US$410.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$345.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$236.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$225.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$205.88m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$203.83m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Biodiffusion chambers for advanced cell culture and drug screening applications.
CPC A61K31/7125, A61M31/002, C07K16/2896Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$194.37m across 11 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic Kv7 potassium channel activators for neurological and psychiatric disorders
CPC A61K31/428, C07D235/30, C07D235/32Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$192.80m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$177.80m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Precise transcranial magnetic stimulation coil positioning, monitoring, and brain‑target modeling.
CPC A61N2/006, A61N2/02, A61N2/008Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$177.37m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted siRNA delivery via FN3 domains binding CD71 for enzyme replacement therapy
CPC C12N15/1138, C07K14/78, A61K47/6435Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$175.95m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Spinal intervertebral fixation implants with tissue‑sparing insertion mechanisms
CPC A61F2/4455, A61F2/447, A61F2/4465Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$158.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$157.75m across 10 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$152.38m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K38/2278, C07K14/62, A61K38/24Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$151.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$145.00m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Small‑molecule inhibitors of kinases and epigenetic enzymes for oncology therapeutics.
CPC C07D487/04, C07D487/14, C07D495/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Meet the people behind life sciences companies in Pennsylvania. 489 of 670 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
Nutraceuticals techManufacturer of nutraceuticals products for multiple diseases
Nutraceuticals techInnovative supplement manufacturer offering custom formulations and turnkey solutions
Life sciences platforms and toolsAdvanced chirality products and custom purification services
Founders
Details not available
OncologyDeveloper of small molecule drugs for cancer treatment
Disease self managementDeveloper of wireless ECG monitor for personal health monitoring use
GenomicsDeveloper of a smartphone-based DNA detection platform
OncologyProvider of drugs and diagnostics kits and therapeutics for liver cancer
Life sciences platforms and toolsOffers laboratory services products
Life sciences techProvider of pH and dissolved oxygen monitoring systems for cell cultivation process
Healthcare itAI based data management and analytics solutions for healthcare organizations
GenomicsProvider of a wide range of sequencing and research services
Founders
Details not available
Life sciences platforms and toolsDeveloper of protein-polymer conjugates for drug delivery
Focus: Patents concentrated in computing, sensing & instrumentation
CPC G01N33/5758, A61P31/12, A23L33/105Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.57m across 10 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$96.40m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$39.65m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Non‑invasive physiological monitoring and diabetes screening devices
CPC A61B5/0261, A61B5/14517, A61B3/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$6.20m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Point‑of‑care nucleic acid sample preparation and rapid molecular diagnostic devices
CPC C12Q1/686, C12N15/1017, C12Q1/6848Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.26m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A61K47/58, C07K1/22, A61K38/465Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in Pennsylvania with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
GenomicsDeveloper of genetic medicines to treat rare diseases
Rare diseasesDeveloper of CAAR T cells for B cell-mediated autoimmune diseases
Rare diseasesDeveloper of tissue-targeted genetic medicines for rare diseases
Cardiac and vascular disordersDeveloper of a device for removal of vascular blockages
ImmunotherapyDeveloper of antibody-based therapeutics for treating cancer
NeurologyDeveloper of small molecule drugs for neurodegenerative diseases
Hospital equipmentProvides hardware and software solutions for remote medication management
Life sciences platforms and toolsDeveloper of protein-polymer conjugates for drug delivery
GenomicsPrecision medicine for complex diseases through advanced genetics and data analysis
NeurologyDeveloper of pharmaceuticals that repair the gut-brain axis to treat patient suffering from neurodegenerative diseases
GastroenterologyInnovative medical device company engineering motion for unmet clinical needs
Healthcare itProvider of a wearable device for breathing monitoring
Focus: Ophthalmic and dermatological biologic therapeutics, including CFTR protein delivery and cytokine cancer treatments.
CPC A61K35/763, C12N15/86, A61K48/005Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$88.26m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$177.37m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted siRNA delivery via FN3 domains binding CD71 for enzyme replacement therapy
CPC C12N15/1138, C07K14/78, A61K47/6435Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$110.42m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Drug‑coated, serrated‑balloon catheters for targeted vascular lesion therapy
CPC A61M25/104, A61M25/1029, A61B17/320725Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$54.19m across 13 disclosed equity rounds
Darker bars = larger roundsFocus: Antibody‑drug conjugates and fluorinated benzodiazepine therapeutics for cancer treatment
CPC C07K16/244, C07K16/30, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$36.09m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Small-molecule therapeutics for neurodegenerative and lysosomal storage diseases
CPC A61K31/4035, C07D209/44, C07C217/62Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$42.19m across 14 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A61K47/58, C07K1/22, A61K38/465Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$6.50m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$51.89m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Aminosterol and squalamine-derived pharmaceutical compounds and formulations
CPC A61K31/575, C07J41/0005, A61K31/58Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$6.36m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: AI-powered respiratory monitoring and physiological signal analysis for health diagnostics
CPC A61B5/4842, G16H50/20, A61B5/7203Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in Pennsylvania founded in the last four years, newest first.
Developer of medical products for treating chronic skin wound conditions
OncologyDeveloper of a novel therapeutic focused on cancer cell metabolism
OphthalmologyDeveloper of technologies for early detection and monitoring of ocular diseases
OphthalmologyDeveloper of digital slit lamp technology for ophthalmic medical devices
Founders
Details not available
Wound careManufacturer of tissue-based products supporting tissue repair and wound care
Founders
Details not available
Developer of live cell imaging and analysis platforms and assays
Founders
Details not available
Developer of rose bengal-based therapies for infectious keratitis and other eye diseases
Founders
Details not available
Life sciences platforms and toolsDeveloper of organoid models for personalized drug therapies for brain disorders
OncologyDeveloper of therapeutics for cancer treatment
ImmunotherapyDeveloper of immunotherapies to treat multiple diseases
NeurologyProvider of medical devices to assist in regenerating peripheral nerve injuries
Founders
Details not available
Life sciences platforms and toolsDeveloper of foundation models for biomedical applications across multiple modalities
Founders
Details not available
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
GenomicsDeveloper of genetic medicines to treat rare diseases
DermatologyDeveloper of therapeutic solutions for skin diseases such as molluscum contagiosum, and others
Genitourinary disordersProvider of surgical devices for vertical hernia repair and abdominal wall reconstruction
Hospital equipmentProvider of medical devices for emergency medicine and various health conditions
NeurologyTransforming neurohealth with innovative, non-drug TMS therapy for mental health
Infectious diseasesProvider of point-of-care diagnostic devices for oral fluid specimens
ImmunotherapyDeveloper of novel cancer immunotherapies to treat cancer and infectious disease
Metabolic diseasesProvider of small molecule therapies for endocrine and metabolic disorders
OncologyDeveloper of drugs for the treatment of genitourinary tumors and other major diseases
Rare diseasesDeveloper of therapeutics to treat rare diseases
Rare diseasesDeveloper of therapeutics for rare neurological diseases
DermatologyBiopharmaceutical company empowering patients through therapeutic innovation in immuno-inflammatory conditions
Focus: Ophthalmic and dermatological biologic therapeutics, including CFTR protein delivery and cytokine cancer treatments.
CPC A61K35/763, C12N15/86, A61K48/005Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$27.43m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61M35/003, A61K31/343, A61K31/34Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$104.10m across 9 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Surgical clip/applier systems and intravascular sensing respiratory filtration devices
CPC A61B17/122, A61B17/1285, A61M16/0808Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$177.80m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Precise transcranial magnetic stimulation coil positioning, monitoring, and brain‑target modeling.
CPC A61N2/006, A61N2/02, A61N2/008Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Point‑of‑care sample collection diagnostics and cryosurgical tissue‑ablation devices.
CPC A61B18/0218, G01N33/54388, B01L3/5029Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Engineered T-cell receptor therapies for targeted cancer immunotherapy
CPC A61K38/177, C07K14/7051Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$65.44m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$345.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$82.00m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C07D471/04, A61K31/506, C07D401/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
The most common specialisations among life sciences companies in Pennsylvania. Open a company to see what it sells, who runs it and how far it has come.
101 life sciences companies in Pennsylvania work in life sciences tech. Shown: the best-documented.
Life sciences techProvider of laboratory management solutions

Life sciences techProvider of software solutions for conducting clinical trials
Clinical labs itProvider of an AI and cloud-based digital pathology solution for cancer diagnosis
Life sciences techProvider of compliance automation software for pharmaceutical industries
Healthcare itProvider of medical device regulatory management software for healthcare organizations
Life sciences techDevelops pharmacology platform to identify pre-clinical and development stage drug candidates
Life sciences techDeveloper of a drug discovery platform for cancer therapies
MarketingtechCustomer Engagement & Digital Solutions Company dedicated to enabling pharmaceutical and life sciences companies
Life sciences techAccelerating clinical research enrollment through patient-centric solutions and supportive communities
Life sciences techDeveloper of a platform for tissue-based biomarker discovery and clinical trials
Life sciences techClinical drug supply chain software and services
Life sciences techDeveloping innovative therapeutics targeting protein degradation for challenging diseases

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$11.60m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Clinical trial risk prediction platform and secure data reader; rotary fan press technology.
CPC G16H10/20, G16H50/30, G07D7/1205Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$129.23m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: AI-driven image analysis and workflow automation for digital pathology diagnostics
CPC G06T7/0012, G16H50/30, G16H30/40Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.12m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Oral zirconium silicate potassium binders for hyperkalemia treatment
CPC A61K33/24, C01G25/00, B01J39/02Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$25.80m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$3.32m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Small-molecule drugs for treating dyskinesia and related neurological movement disorders
CPC A61K31/497, A61K31/506, C07D413/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$55.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic antibodies targeting CD161 for immune modulation and related diagnostics
CPC C07K16/2851Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.80m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.90m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: USP7-targeted covalent azole inhibitors for cancer immunotherapy
CPC G01N33/543, C12Q1/25, A61K31/4436Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
99 life sciences companies in Pennsylvania work in oncology. Shown: the best-documented.
Women healthProvider of a non-invasive breast cancer scanning device

OncologyDeveloper of small-molecule innate immune modulators for cancer therapy

ImmunotherapyDeveloper of novel cancer immunotherapies to treat cancer and infectious disease
OncologyDeveloper of chromatin function targeting drugs for the treatment of cancer and rare diseases
OncologyDeveloper of therapeutics for the treatment of autoimmune diseases and cancer
OncologyProvides telomere length analysis technology for diagnosis
ImmunotherapyPersonalized immunotherapies targeting solid tumors, stimulating innate and adaptive immunity
OncologyDeveloper of therapeutics for the treatment of cancer
OncologyDeveloper of therapies for cancer treatment
Founders
Details not available
ImmunotherapyDeveloper of antibody-based therapeutics for treating cancer
OncologyDeveloper of chemoprotective agents for oral mucositis associated with chemotherapy
OncologyDeveloper of small molecule drugs for cancer treatment
US$4.76m across 4 disclosed equity rounds
Darker bars = larger rounds
Focus: Capacitive tactile sensors for non‑invasive tissue property measurement and lesion mapping
CPC A61F2/3094, A61B5/0053, A61F2/4455Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Engineered T-cell receptor therapies for targeted cancer immunotherapy
CPC A61K38/177, C07K14/7051Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$145.00m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Small‑molecule inhibitors of kinases and epigenetic enzymes for oncology therapeutics.
CPC C07D487/04, C07D487/14, C07D495/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$410.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$203.83m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Biodiffusion chambers for advanced cell culture and drug screening applications.
CPC A61K31/7125, A61M31/002, C07K16/2896Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$236.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$119.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$54.19m across 13 disclosed equity rounds
Darker bars = larger roundsFocus: Antibody‑drug conjugates and fluorinated benzodiazepine therapeutics for cancer treatment
CPC C07K16/244, C07K16/30, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$144.24m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Metal‑chelate macrocyclic complexes for oral cancer drugs and radiopharmaceutical protection
CPC A61K31/555, C07F13/005, A61K31/375Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$96.40m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
89 life sciences companies in Pennsylvania work in life sciences platforms and tools. Shown: the best-documented.
GenomicsDeveloper of a smartphone-based DNA detection platform
Life sciences platforms and toolsDeveloping long acting formulation for opioid addiction
Life sciences techDevelops pharmacology platform to identify pre-clinical and development stage drug candidates
Life sciences platforms and toolsDeveloper of protein-polymer conjugates for drug delivery
Provider of drug discovery platform for different diseases
Life sciences platforms and toolsNovel continuous counter-current tangential chromatography-based separation technology
Life sciences platforms and toolsProvider of nuclear receptor and in vitro toxicology solutions
Life sciences platforms and toolsDeveloper of AI-based platform for lab-grown human tissues
Life sciences platforms and toolsNoninvasive vital signs monitoring systems specifically designed for small laboratory animals
Founders
Details not available
Life sciences platforms and toolsInnovative non-opioid pain management solutions for acute and chronic pain
Life sciences platforms and toolsProvider of 3D bio-printers and services
Life sciences platforms and toolsProvider of rehabilitation care services
US$6.20m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Point‑of‑care nucleic acid sample preparation and rapid molecular diagnostic devices
CPC C12Q1/686, C12N15/1017, C12Q1/6848Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Vehicle temperature control systems for passenger and commercial vehicles.
CPC B60H1/00742Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$3.32m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Small-molecule drugs for treating dyskinesia and related neurological movement disorders
CPC A61K31/497, A61K31/506, C07D413/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A61K47/58, C07K1/22, A61K38/465Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$5.32m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Continuous countercurrent spiral chromatography systems for high‑efficiency liquid separations
CPC B01D15/1807, G01N30/42Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.28m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$117.69m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$2.31m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$7.51m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.50m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Manufacturing scanning antennas for RFID and wireless communication systems
CPC H04B7/2643, H04W72/23, H04B7/0842Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
69 life sciences companies in Pennsylvania work in neurology. Shown: the best-documented.
NeurologyTransforming neurohealth with innovative, non-drug TMS therapy for mental health
NeurologyProvider of a non-drug non-invasive therapeutic devices for neurorehabilitation
NeurologyDeveloper of genetic tests for personalised medicines to enhance mental health treatment
Life sciences platforms and toolsDeveloping long acting formulation for opioid addiction
NeurologyDeveloper of GPCR ligand technology based therapeutics for cardiovascular diseases and pain
NeurologyDeveloper of neurological rehabilitation medical devices
NeurologyDeveloper of small molecule drugs for neurodegenerative diseases
NeurologyDeveloper of small-molecule therapeutics for the treatment of CNS and inflammatory diseases
Gene therapyDeveloper of cell and gene therapies to treat multiple diseases
NeurologyDeveloper of pharmaceuticals that repair the gut-brain axis to treat patient suffering from neurodegenerative diseases
Healthcare itNeurological monitoring solutions
NeurologyDeveloper of gene therapies for the treatment of neurodegenerative diseases
US$177.80m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Precise transcranial magnetic stimulation coil positioning, monitoring, and brain‑target modeling.
CPC A61N2/006, A61N2/02, A61N2/008Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$118.69m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$64.42m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Pharmacogenomic allele detection and reporting for mental health drug response
CPC C12Q1/6883, A61K31/554, G16B20/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Vehicle temperature control systems for passenger and commercial vehicles.
CPC B60H1/00742Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$119.00m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C07K7/06, C07D401/12, A61K31/4436Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$36.09m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Small-molecule therapeutics for neurodegenerative and lysosomal storage diseases
CPC A61K31/4035, C07D209/44, C07C217/62Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$194.37m across 11 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic Kv7 potassium channel activators for neurological and psychiatric disorders
CPC A61K31/428, C07D235/30, C07D235/32Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$80.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$51.89m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Aminosterol and squalamine-derived pharmaceutical compounds and formulations
CPC A61K31/575, C07J41/0005, A61K31/58Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$25.85m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
207 more company lists you can search, plus the Radar directory pages for each place.
No list matches. Try a shorter word.
We will reply with coverage, fields and pricing for your use case.
Filed revenue, profit and growth for every company on this page are available with a Radar account. Log in and you will come straight back here with all figures open.